Philadelphia Financial Management of San Francisco LLC Acquires New Holdings in Metlife Inc (MET)

Share on StockTwits

Philadelphia Financial Management of San Francisco LLC acquired a new position in shares of Metlife Inc (NYSE:MET) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 155,492 shares of the financial services provider’s stock, valued at approximately $6,385,000.

Other large investors have also recently made changes to their positions in the company. JNBA Financial Advisors purchased a new stake in shares of Metlife during the fourth quarter worth $26,000. Bruderman Asset Management LLC purchased a new stake in shares of Metlife during the fourth quarter worth $27,000. Berman Capital Advisors LLC purchased a new stake in shares of Metlife during the fourth quarter worth $31,000. Country Trust Bank raised its holdings in shares of Metlife by 1,052.6% during the fourth quarter. Country Trust Bank now owns 876 shares of the financial services provider’s stock worth $36,000 after acquiring an additional 800 shares in the last quarter. Finally, Founders Capital Management purchased a new stake in shares of Metlife during the fourth quarter worth $37,000. Institutional investors and hedge funds own 76.22% of the company’s stock.

NYSE MET opened at $43.38 on Thursday. Metlife Inc has a fifty-two week low of $37.76 and a fifty-two week high of $48.92. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.14 and a current ratio of 0.14. The stock has a market cap of $41.53 billion, a price-to-earnings ratio of 8.05, a P/E/G ratio of 0.97 and a beta of 1.20.

Metlife (NYSE:MET) last posted its earnings results on Wednesday, February 6th. The financial services provider reported $1.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.05. Metlife had a return on equity of 10.24% and a net margin of 7.53%. The company had revenue of $15.40 billion for the quarter, compared to analyst estimates of $15.84 billion. During the same period last year, the company earned $0.64 earnings per share. The business’s revenue was up .0% compared to the same quarter last year. Analysts anticipate that Metlife Inc will post 5.48 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Shareholders of record on Tuesday, February 5th were issued a dividend of $0.42 per share. The ex-dividend date was Monday, February 4th. This represents a $1.68 annualized dividend and a yield of 3.87%. Metlife’s dividend payout ratio (DPR) is currently 31.17%.

Several analysts recently issued reports on the company. Royal Bank of Canada cut their price objective on Metlife from $57.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, December 17th. ValuEngine upgraded Metlife from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. Zacks Investment Research lowered Metlife from a “buy” rating to a “hold” rating in a report on Monday, January 21st. Sandler O’Neill upgraded Metlife from a “hold” rating to a “buy” rating in a report on Wednesday, January 2nd. Finally, Argus restated a “buy” rating on shares of Metlife in a report on Tuesday, February 12th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $52.92.

In other news, EVP Steven J. Goulart sold 10,292 shares of Metlife stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $44.40, for a total value of $456,964.80. Following the transaction, the executive vice president now directly owns 93,214 shares in the company, valued at $4,138,701.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John D. Mccallion sold 2,669 shares of Metlife stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $44.43, for a total value of $118,583.67. Following the completion of the transaction, the chief financial officer now owns 20,538 shares in the company, valued at $912,503.34. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/4238713/philadelphia-financial-management-of-san-francisco-llc-acquires-new-holdings-in-metlife-inc-met.html.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Article: Technical Analysis

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Comparing Emmis Communications  and Spotify Technology
Comparing Emmis Communications and Spotify Technology
Head-To-Head Review: Twist Bioscience  and Regenxbio
Head-To-Head Review: Twist Bioscience and Regenxbio
Meet Group  Rating Lowered to Strong Sell at BidaskClub
Meet Group Rating Lowered to Strong Sell at BidaskClub
Facebook’s  Buy Rating Reiterated at Royal Bank of Canada
Facebook’s Buy Rating Reiterated at Royal Bank of Canada
Carpenter Technology  Given a $59.00 Price Target by Longbow Research Analysts
Carpenter Technology Given a $59.00 Price Target by Longbow Research Analysts
Southern First Bancshares  Downgraded to Hold at BidaskClub
Southern First Bancshares Downgraded to Hold at BidaskClub


© 2006-2019 Ticker Report